Night‐Time Apomorphine Infusion: Who Are the Best Candidates?
Movement Disorders Clinical Practice · 2023-08 · 10 (8) · 1192-1197
DOI: 10.1002/mdc3.13799 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 13.06.2023. Verfasst von Valérie Cochen De Cock und 16 weiteren Autor:innen. Beteiligte Einrichtung: Sleep and Neurology Department Beau Soleil Clinic Montpellier France. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
We recently demonstrated in a randomized controlled trial (APOMORPHEE, NCT02940912) that night‐time only subcutaneous apomorphine infusion improves sleep disturbances and insomnia in patients with advanced Parkinson's disease and moderate to severe insomnia.
Objectives
To identify the best candidates for receiving night‐time only subcutaneous apomorphine infusion in routine care.
Methods
In this post‐hoc analysis of APOMORPHEE, we compared the characteristics of patients according to whether they chose to continue night‐time only subcutaneous apomorphine infusion at the end of the study period or not.
Results
Half of the patients (22/42) chose to continue the treatment. Off duration (day or night), painful Off dystonia, and insomnia severity at baseline were associated with night‐time only apomorphine continuation. Multivariate analysis retained only Off duration as an independent predictor of continuation.
Conclusions
The best candidates for night‐time only apomorphine are patients with severe and prolonged Off periods (day or night) and severe insomnia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sleep and Neurology Department Beau Soleil Clinic Montpellier France.
- EuroMov Digital Health in Motion Univ Montpellier, IMT Mines Alès Montpellier France.
- Sleep Disorders Unit Pitié-Salpêtrière University Hospital Paris France.
- Sleep Department University Hospital of Nîmes Nîmes France.
- Department of Neurology University Hospital of Nîmes Nîmes France.
- Clinique du Millénaire Montpellier France.
ORCID-Profile: Valérie Cochen De Cock, Isabelle Arnulf
Zitieren
APA
Cochen De Cock, V., Dodet, P., Leu-Semenescu, S., Aerts, C., Abril, B., Castelnovo, G., Landragin, N., Drapier, S., Olivet, H., Corbillé, A. G., Leclair-Visonneau, L., Anheim, M., Vidailhet, M., Arnulf, I., Doulazmi, M., Roze, E., & Post‐hoc analysis of the APOMORPHEE study (2023). Night‐Time Apomorphine Infusion: Who Are the Best Candidates?. Movement Disorders Clinical Practice, 10(8), 1192-1197. https://doi.org/10.1002/mdc3.13799
Vancouver
Cochen De Cock V, Dodet P, Leu-Semenescu S, Aerts C, Abril B, Castelnovo G, et al. Night‐Time Apomorphine Infusion: Who Are the Best Candidates?. Movement Disorders Clinical Practice. 2023;10(8):1192-1197. doi:10.1002/mdc3.13799
BibTeX
@article{CochenDeCock2023,
author = {Cochen De Cock, Valérie and Dodet, Pauline and Leu-Semenescu, Smaranda and Aerts, Cécile and Abril, Beatriz and Castelnovo, Giovanni and Landragin, Nicolas and Drapier, Sophie and Olivet, Hélène and Corbillé, Anne-Gaëlle and Leclair-Visonneau, Laurène and Anheim, Mathieu and Vidailhet, Marie and Arnulf, Isabelle and Doulazmi, Mohamed and Roze, Emmanuel and Post‐hoc analysis of the APOMORPHEE study, Post‐hoc analysis of the APOMORPHEE study},
title = {Night‐Time Apomorphine Infusion: Who Are the Best Candidates?},
journal = {Movement Disorders Clinical Practice},
year = {2023},
volume = {10},
number = {8},
pages = {1192--1197},
doi = {10.1002/mdc3.13799}
}
EUVIMED